Comparison of sample preparation methods for ChIP-chip assays

被引:107
作者
O'Geen, Henriette
Nicolet, Charles M.
Blahnik, Kim
Green, Roland
Farnham, Peggy J.
机构
[1] Univ Calif Davis, Genome & Biomed Sci Facil, Davis, CA 95616 USA
[2] NimbleGen Syst Inc, Madison, WI USA
关键词
D O I
10.2144/000112268
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A single chromatin immunoprecipitation (ChIP) sample does not provide enough DNA for hybridization to a genomic tiling array. A commonly used technique for amplifying the DNA obtained from ChIP assays is ligation-mediated PCR (LM-PCR). However using this amplification method, we could not identify Oct4 binding sites on genomic tiling arrays representing 1% of the human genome (ENCODE arrays). In contrast, hybridization of a pool of 10 ChIP samples to the arrays produced reproducible binding patterns and low background signals. However the pooling method would greatly increase the number of ChIP reactions needed to analyze the entire human genome. Therefore, we have adapted the GenomePlex (R) whole genome amplification (WGA) method for use in ChIP-chip assays; detailed ChIP and amplification protocols used for these analyses are provided as supplementary material. When applied to ENCODE arrays, the products prepared using this new method resulted in an Oct4 binding pattern similar to that from the pooled Oct4 ChIP samples. Importantly, the signal-to-noise ratio using the GenomePlex WGA method is superior to the LM-PCR amplification method.
引用
收藏
页码:577 / 580
页数:4
相关论文
共 10 条
  • [1] Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome
    Bieda, M
    Xu, XQ
    Singer, MA
    Green, R
    Farnham, PJ
    [J]. GENOME RESEARCH, 2006, 16 (05) : 595 - 605
  • [2] Myc versus USF: Discrimination at the cad gene is determined by core promoter elements
    Boyd, KE
    Farnham, PJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (05) : 2529 - 2537
  • [3] Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo
    Grandori, C
    Mac, J
    Siebelt, F
    Ayer, DE
    Eisenman, RN
    [J]. EMBO JOURNAL, 1996, 15 (16) : 4344 - 4357
  • [4] JIN V, IN PRESS GENOME RES
  • [5] A high-resolution map of active promoters in the human genome
    Kim, TH
    Barrera, LO
    Zheng, M
    Qu, CX
    Singer, MA
    Richmond, TA
    Wu, YN
    Green, RD
    Ren, B
    [J]. NATURE, 2005, 436 (7052) : 876 - 880
  • [6] Oberley MJ, 2004, METHOD ENZYMOL, V376, P315
  • [7] E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9
    Oberley, MJ
    Inman, DR
    Farnham, PJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) : 42466 - 42476
  • [8] Suz12 binds to silenced regions of the genome in a cell-type-specific manner
    Squazzo, Sharon L.
    O'Geen, Henriette
    Komashko, Vitalina M.
    Krig, Sheryl R.
    Jin, Victor X.
    Jang, Sung-wook
    Margueron, Raphael
    Reinberg, Danny
    Green, Roland
    Farnham, Peggy J.
    [J]. GENOME RESEARCH, 2006, 16 (07) : 890 - 900
  • [9] Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis
    Weinmann, AS
    Yan, PS
    Oberley, MJ
    Huang, THM
    Farnham, PJ
    [J]. GENES & DEVELOPMENT, 2002, 16 (02) : 235 - 244
  • [10] Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase
    Wells, J
    Yan, PS
    Cechvala, M
    Huang, T
    Farnham, PJ
    [J]. ONCOGENE, 2003, 22 (10) : 1445 - 1460